Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells

Abstract

Induction of a cyclin-dependent kinase inhibitor p21Waf1/Cip1/Sdi1 is an integral part of cell growth arrest associated with senescence and damage response. p21 overexpression from an inducible promoter resulted in senescence-like growth arrest in a human fibrosarcoma cell line. After release from p21-induced growth arrest, cells re-entered the cell cycle but displayed growth retardation, cell death and decreased clonogenicity. The failure to form colonies was associated with abnormal mitosis and endoreduplication in the recovering cells and was correlated with the induced level of p21 and the duration of p21 induction. p21 induction was found to inhibit the expression of multiple proteins involved in the execution and control of mitosis. p21-induced depletion of the cellular pools of mitosis-control proteins was followed by asynchronous resynthesis of such proteins after release from p21, which explains the observed mitotic abnormalities. Genetic destabilization in cells recovering from p21-induced growth arrest may conceivably play a role in carcinogenesis and tumor progression.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 2
Figure 1
Figure 3
Figure 4

Similar content being viewed by others

References

  • Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D and Barrett JC . 1996 Proc Natl Acad Sci USA 93: 13742–13747

  • Bates S, Ryan KM, Phillips AC and Vousden KH . 1998 Oncogene 17: 1691–1703

  • Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B . 1998 Science 282: 1497–1501

  • Chan GK, Jablonski SA, Sudakin V, Hittle JC and Yen TJ . 1999 J Cell Biol 146: 941–954

  • Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y, Kandel ES, Lausch E, Christov K and Roninson IB . 1999b Cancer Res 59: 3761–3767

  • Chang BD, Xuan Y, Broude EV, Zhu H, Schott B, Fang J and Roninson IB . 1999a Oncogene 18: 4808–4818

  • Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV and Roninson IB . 2000 Proc Natl Acad Sci USA in press

  • Deng C, Zhang P, Harper JW, Elledge SJ and Leder P . 1995 Cell 82: 675–684

  • DiLeonardo A, Linke SP, Clarkin K and Wahl GM . 1994 Genes Develop 8: 2540–2551

  • Dimri GP, Nakanishi M, Desprez PY, Smith JR and Campisi J . 1996 Mol Cell Biol 16: 2987–2997

  • Fang L, Igarashi M, Leung J, Sugrue MM, Lee SW and Aaronson SA . 1999 Oncogene 18: 2789–2797

  • Gartel AL and Tyner AL . 1998 Inhibitors of Cell Growth, Progress in Molecular and Subcellular Biology, Vol 20 Macieir-Coelho A ed Springer-Verlag Berlin-Heidelberg pp 43–71

  • Gerring SL, Spencer F and Hieter P . 1990 EMBO J 9: 4347–4358

  • Glover DM, Hagan IM and Tavares AA . 1998 Genes Dev 12: 3777–3787

  • Hall M and Peters G . 1996 Adv Cancer Res 68: 67–108

  • Hendrickson M, Madine M, Dalton S and Gautier J . 1996 Proc Natl Acad Sci USA 93: 12223–12228

  • Hixon ML, Flores AI, Wagner MW and Gualberto A . 1998 Mol Cell Biol 18: 6224–6237

  • Jiang W, Jimenez G, Wells NJ, Hope TJ, Wahl GM, Hunter T and Fukunaga R . 1998 Mol Cell 2: 877–885

  • Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H and Wilson L . 1996 Cancer Res 56: 816–825

  • Kalitsis P, MacDonald AC, Newson AJ, Hudson DF and Choo KHA . 1998 Genomics 47: 108–114

  • Kikuchi J, Furukawa Y, Iwase S, Terui Y, Nakamura M, Kitagawa S, Kitagawa M, Komatsu N and Miura Y . 1997 Blood 89: 3980–3990

  • Kimura M, Kotani S, Hattori T, Sumi N, Yoshioka T, Todokoro K and Okano Y . 1997 J Biol Chem 272: 13766–13771

  • Kishimoto T and Okumura E . 1997 Prog Cell Cycle Res 3: 241–249

  • Kuriyama R, Kofron M, Essner R, Kato T, Dragas-Granoic S, Omoto CK and Khodjakov A . 1995 J Cell Biol 129: 1049–1059

  • Li Y and Benezra R . 1996 Science 274: 246–248

  • Liao H, Winkfein RJ, Mack G, Rattner JB and Yen TJ . 1995 J Cell Biol 130: 507–518

  • Madaule P, Eda M, Watanabe N, Fujisawa K, Matsuoka T, Bito H, Ishizaki T and Narumiya S . 1998 Nature 394: 491–494

  • Mahbubani HM, Chong JP, Chevalier S, Thommes P and Blow JJ . 1997 J Cell Biol 136: 125–135

  • McConnell BB, Starborg M, Brookes S and Peters G . 1998 Curr Biol 8: 351–354

  • Nevins JR . 1998 Cell Growth Differ 9: 585–593

  • Niculescu AB, Chen X, Smeets M, Hengst L, Prives C and Reed SI . 1998 Mol Cell Biol 18: 629–643

  • Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR . 1994 Exp Cell Res 211: 90–98

  • Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD and Roninson IB . 1990 Proc Natl Acad Sci USA 87: 7160–7164

  • Robles SJ and Adami GR . 1998 Oncogene 16: 1113–1123

  • Schimke RT, Kung AL, Rush DF and Sherwood SW . 1991 Cold Spring Harb Symp Quant Biol 56: 417–425

  • Schimke RT, Sherwood SW, Hill AB and Johnston RN . 1986 Proc Natl Acad Sci USA 83: 2157–2161

  • Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW . 1997 Cell 88: 593–602

  • Stein GH, Drullinger LF, Soulard A and Dulic V . 1999 Mol Cell Biol 19: 2109–2117

  • Terada Y, Tatsuka M, Suzuki F, Yasuda Y, Fujita S and Otsu M . 1998 EMBO J 17: 667–676

  • Vogt M, Haggblom C, Yeargin J, Christiansen-Weber T and Haas M . 1998 Cell Growth Differ 9: 139–146

Download references

Acknowledgements

We thank Drs W Jiang and T Hunter for the Prc1 antibody, M Chmyra and Dr Y Verlinsky for FISH assays, Dr K Hagen for assistance with flow sorting, H Zhu, Y Chen, V Jovasevic and Drs V Levenson, M Swift and S Salov for help with some experiments, and Drs T Primiano and RL Davidson for helpful discussions. This work was supported by grants R01CA62099 and R37CA40333 from the National Cancer Institute (IB Roninson).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, BD., Broude, E., Fang, J. et al. p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 19, 2165–2170 (2000). https://doi.org/10.1038/sj.onc.1203573

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203573

Keywords

This article is cited by

Search

Quick links